Ability to Assess Your Risk of Having a Heart Attack

For peace of mind, ask your Healthcare Provider about getting tested today.

HeartForce CardioClin Medical Device coronary artery disease risk screening
Coming soon

Check CardioClin™ Availability

We are currently preparing for commercial launch across Europe and Canada, pending final regulatory clearances anticipated for early 2027. Contact us to be notified the moment CardioClin™ becomes available at clinics near you.

Rx

Please note: CardioClin™ is a prescription-only (Rx) screening tool intended to assist healthcare professionals in evaluating CAD risk. It is not available for direct consumer purchase or home use. Consult your physician or qualified healthcare provider for all medical advice and diagnostic testing.

Most heart attacks are caused by coronary artery disease

Coronary artery disease (CAD) develops when fatty plaque slowly builds up in the arteries that supply your heart, making them narrower. When an artery becomes blocked, blood can no longer reach part of the heart muscle – this is a heart attack.

With symptoms

Some people notice warning signs

Without symptoms

Others feel fine, but have risk factors

1 in 3

For about one in three people without symptoms, the first heart attack is fatal.

Screening for CAD risk is not optimal today, so many heart attacks that could have been prevented still happen. Most people don’t know this. Knowing your risk early gives you and your doctor the chance to act.

Learn more about CAD

Comparison of normal and blocked artery

What is Coronary Artery Disease

Explore the risks of the world’s deadliest disease.

Limitations of Current CAD Tests

Learn about the silent threat—and why you and your loved ones should get tested today.

You are leaving the US website

You are leaving the US version of the HeartForce website and entering our global website.

Product availability, regulatory status, risk categorisation, and performance claims may differ between regions and may not apply to the United States.

CardioClin™ is not cleared or approved by the U.S. Food and Drug Administration (FDA).

Please return to the US website for information applicable to the United States.